LILY HILL: Open Payments
NPI 1275882706 · RAVENSWOOD, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$770 in 40 payments from 15 companies in 2025. Trend: 2023 $728 · 2024 $787 · 2025 $770
Food & beverage: $702Education: $68
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $158 |
| Astellas Pharma US Inc | 2 | $91 |
| Otsuka America Pharmaceutical, Inc. | 4 | $71 |
| Novo Nordisk Inc | 4 | $66 |
| Amgen Inc. | 3 | $61 |
| Lundbeck LLC | 3 | $53 |
| Tandem Diabetes Care, Inc. | 2 | $47 |
| Insulet Corporation | 2 | $45 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| ABBVIE INC. | 2 | $37 |
Products named: CAPLYTA, REXULTI, Otezla, t:slim X2 Insulin Pump with Control-IQ, Ozempic, Omnipod, Auvelity, AFREZZA.
Industry payments across WV — which companies pay providers there.
